Recently (as some of you know) I had stopped all my topicals to see if there would be an improvement in the folliculitis/inflammation of the scalp. It's been about a month now since I stopped and I have found that indeed the inflammation has decreased a lot. Yesterday I tried applying my topicals again to see if I would notice a difference now that I haven't been applying them. Sadly, the inflammation came back with a vengeance in my crown area. My frontal hair line and temples did fine however and were never inflamed to begin with. I am disappointed as this suggests I have developed some kind of an allergic reaction to my treatments. I think it may be the alcohol in the treatments but I'm not certain.
Anyway, I have noticed that shedding, especially in the crown area has increased tremendously now that a month has passed without any Xandrox, Revivogen or regular minoxidil for that matter. I hope the Protopic works, because I think most of my hair loss is from the inflammation. If I can control it, then maybe I can control further loss by just staying on the Propecia. I wish my skin was not so damn sensitive, because I really believe in my treatment regimen. It was working. But sadly I think I have to stay off the topicals indefinitely.... I'm still scaping some cash to eventually purchase a lasercomb.
Those of you who don't get allergic skin reactions consider yourselves lucky. You can use the good topicals. The treatments I will miss the very most will be Xandrox and Revivogen. The Xandrox worked unbelievably well for me, especially along the hair line and in the temples.
The following abstract suggests that Protopic may potentially be useful in Alopecia Areata:
Drugs Today (Barc). 2002 Jan;38(1):7-15. Related Articles, Links
Topical tacrolimus Protopic.
Lazarous MC, Kerdel FA.
Department of Dermatology and Cutaneous Medicine, University of Miami School of Medicine, Miami, FL 33136, USA.
Topical tacrolimus is the first topical immunomodulator of its kind, and its mechanism of action, pharmacokinetics, metabolism and efficacy will be discussed. Multiple studies have supported the safety and efficacy of topical tacrolimus in the treatment of atopic dermatitis in both adults and children. Studies have also suggested that topical tacrolimus may be effective in the treatment of acute contact dermatitis. Although oral administration of tacrolimus proved to be efficacious in psoriasis, results with topical tacrolimus have been disappointing in some studies. Additional reports of success in the use of topical tacrolimus in the treatment of pyoderma gangrenosum show promise, although there is a paucity of randomized, placebo-controlled trials examining its use. It has also been suggested that topical tacrolimus is useful in the treatment of alopecia areata, erosive lichen planus, isolated ichthyosis linearis circumflexa, steroid-induced rosacea, and in the prevention of allograft rejection, however more clinical trials need to be performed.
Sam